Osage Partners related stories
All articles and analysis
VC-Backed Clinipace Worldwide Names New CFOClinipace Worldwide said Tuesday that it named Mark Ubert as CFO. In this role, Ubert leads all aspects of the company’s financial operations including accounting, financial reporting, treasury and tax teams. Backed by NXT Capital, Morgan Stanley Expansion Capital, Hatteras Venture Partners, Brooke Private Equity, Osage Venture Partners and Mario Family Partners, Clinipace is a digital contract research organization in Morrisville, North Carolina.
- Kymeta Closes $50m Series C
Kymeta Corporation has closed a $50 million Series C financing to accelerate the company’s growth plans. Kymeta designs and manufactures satellite communication antennas and systems. Existing Kymeta investors including Bill Gates, Lux Capital and Liberty Global were joined in the financing by Osage University Partners and The Kresge Foundation.
- RackWare Receives $3 Mln from Kickstart Seed Fund and Osage Venture Partners
RackWare said on Thursday that it has received $3 million in Series A funding. Kickstart Seed Fund and Osage Venture Partners led the round. Also, Gavin Christensen, managing director at Seed Fund and Nate Lentz, managing partner at Osage Venture Partners join RackWare’s board of directors. Based in Santa Clara, California and Wayne, Pennsylvania, RackWare is a provider of cloud solutions.
- Canvas Receives $4 Mln in Series C Funding
Canvas, a provider of business mobile apps, said on Monday that it has closed $4 million in Series C funding. The lead investor was Osage Venture Partners. Motorola Solutions Venture Capital, an existing investor, also participated in the round. The financing will be used to expand the company's capabilities and its global market base. Canvas is headquartered in both Reston, Virginia and Sydney, Australia.
Analyze This: Social Analytics Gain TractionAs corporations try to attract and engage customers online, social analytic startups are measuring their impact and raising huge amounts of capital
- eFFECTOR Therapeutics Raises $45 Million Series A
Biopharmaceutical company eFFECTOR Therapeutics has completed a $45 million Series A financing. Investors include U.S. Venture Partners, Abingworth, Novartis Venture Funds, SR One, Astellas Venture Management, Osage University Partners and Mission Bay Capital.
- Cleave Biosciences Adds $10M
Cleave Biosciences has added $10 million in Series A financing from new investor New Enterprise Associates, bringing its Series A total to $54 million. In the fall of 2011, Cleave raised $44 million from US Venture Partners, 5AM Ventures, Clarus Ventures, OrbiMed Advisors, Astellas Venture Management and Osage University Partners. The company is focused on cancer drug discovery and development.
- BA Insight Adds $4.5M in Capital
BA Insight, a developer of advanced search technology, has added $4.5 million, bringing the total amount raised to date to $15.7 million. The company is backed by Milestone Venture Partners, Osage Venture Partners, Paladin Capital Group and Originate Ventures.
- PeopleLinx Raises $3.2M From Osage, Greycroft, MissionOG
PeopleLinx said it raised $3.2 million in Series A funding in a deal led by Osage Venture Partners, Greycroft Partners and MissionOG. Angel investors also participated in the oversubscribed round.
- Pneuron Raises $6 Million Round, Led by Safeguard Scientifics
Safeguard Scientifics, a Wayne, Pa.-based investment company focused on technology and healthcare outfits, has provided $5 million of a new $6 million Series B round of financing raised by Pneuron Corp., a Woburn, Mass.-based company that sells large data integration software applications. Osage Venture Partners, a previous investor in Pneuron, contributed the remaining funding to the round.S